3DPrint.com January 12, 2024
Vanesa Listek

Navigating through the landscape of bioprinting, 2023 unfolded as a year where targeted investments significantly nurtured this specialized field. The ripples of these investments indicate a maturing industry poised for growth. This year’s investment trend in bioprinting was marked by a series of strategic moves aimed at deepening the potential of bioprinting in medical applications.

The investments in 2023 primarily came from public or government sectors, with notable contributions from private entities. A common thread among these investments is their focus on innovative applications in healthcare, aiming to bridge the gap between advanced research and practical medical solutions. From ambitious projects aiming to revolutionize organ transplantation to more focused studies enhancing specific medical treatments, each funding initiative reflected a concerted...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: 3D Printing, Biotechnology, Investments, Pharma / Biotech, Technology, Trends
Related Articles:
How 3D Printing Impacts Radiology
Ricoh’s 3D Printing Improves Surgical Accuracy and Safety One Layer at a Time
3D-printed hydrogel enables continuous drug delivery via contact lens
Improved 3D printed blood vessels thanks to bioink with DNA
DNA-based bioink technology enables precise 3D-printing of blood vessels

Share This Article